Immune regulation via T lymphocyte subsets

Immune regulation via T lymphocyte subsets is a complex biological process rather than a single molecular target, involving the coordinated activity of various T cell lineages to maintain immune homeostasis and respond to threats. This system includes CD4+ helper T cells (Th1, Th2, Th17), CD8+ cytotoxic T cells, and regulatory T cells (Tregs), which are characterized by specific transcription factors such as FOXP3 and distinct cytokine profiles (Source: StatPearls). In clinical contexts, this process is modulated to treat autoimmune diseases, where the goal is to enhance regulatory functions, or in oncology, where the goal is to inhibit suppressive subsets to promote anti-tumor activity (Source: PubMed). Because it represents a physiological mechanism, it is addressed therapeutically through a wide variety of specific molecular targets, including checkpoint receptors like PD-1 and CTLA-4, as well as various interleukins and their receptors (Source: NIH). Consequently, while it is a central concept in immunology and drug development, it does not refer to a single protein or receptor but to the functional output of the T-cell compartment (Source: NCBI).

Other names

T-cell mediated immune regulationT-lymphocyte subset modulationRegulation of T-cell mediated immunityAdaptive immune regulation

Modulation of T-cell activation, differentiation, and effector function through the targeting of specific surface receptors (e.g., TCR, CD28, PD-1, CTLA-4) or cytokine signaling pathways to shift the balance between effector and regulatory populations.